1. Home
  2. SLB vs EW Comparison

SLB vs EW Comparison

Compare SLB & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLB
  • EW
  • Stock Information
  • Founded
  • SLB 1926
  • EW 1958
  • Country
  • SLB United States
  • EW United States
  • Employees
  • SLB N/A
  • EW N/A
  • Industry
  • SLB Oilfield Services/Equipment
  • EW Industrial Specialties
  • Sector
  • SLB Energy
  • EW Health Care
  • Exchange
  • SLB Nasdaq
  • EW Nasdaq
  • Market Cap
  • SLB 47.4B
  • EW 44.6B
  • IPO Year
  • SLB N/A
  • EW 2000
  • Fundamental
  • Price
  • SLB $33.05
  • EW $78.20
  • Analyst Decision
  • SLB Strong Buy
  • EW Buy
  • Analyst Count
  • SLB 19
  • EW 20
  • Target Price
  • SLB $53.63
  • EW $80.20
  • AVG Volume (30 Days)
  • SLB 12.8M
  • EW 4.2M
  • Earning Date
  • SLB 07-18-2025
  • EW 07-23-2025
  • Dividend Yield
  • SLB 3.45%
  • EW N/A
  • EPS Growth
  • SLB N/A
  • EW 200.69
  • EPS
  • SLB 2.96
  • EW 7.02
  • Revenue
  • SLB $36,072,000,000.00
  • EW $5,522,300,000.00
  • Revenue This Year
  • SLB N/A
  • EW $11.68
  • Revenue Next Year
  • SLB $3.82
  • EW $9.50
  • P/E Ratio
  • SLB $11.18
  • EW $11.14
  • Revenue Growth
  • SLB 5.76
  • EW 8.23
  • 52 Week Low
  • SLB $31.11
  • EW $58.93
  • 52 Week High
  • SLB $50.94
  • EW $95.25
  • Technical
  • Relative Strength Index (RSI)
  • SLB 37.33
  • EW 63.10
  • Support Level
  • SLB $33.10
  • EW $74.20
  • Resistance Level
  • SLB $34.36
  • EW $78.75
  • Average True Range (ATR)
  • SLB 0.73
  • EW 1.48
  • MACD
  • SLB -0.07
  • EW -0.01
  • Stochastic Oscillator
  • SLB 5.09
  • EW 89.15

About SLB Schlumberger N.V.

SLB is the world's premier oilfield-services company as measured by market share. While the industry is mostly fragmented, SLB holds the first or second competitive position in many of the differentiated oligopolies it operates in. Also known as Schlumberger, the company was founded in 1926 by two brothers bearing the same last name. Today it's most known as a global industry leader in innovation, while it focuses its strategy on its three growth engines: its core, digital, and new energy businesses. Over three fourths of its revenue base is tied to international markets, while the company boasts roughly $3 billion in digital-related revenue.

About EW Edwards Lifesciences Corporation

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

Share on Social Networks: